Patents by Inventor Martin Philpott

Martin Philpott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OLIGONUCLEOTIDES
    Publication number: 20240102091
    Abstract: The invention relates to methods of adding identifier sequences to polynucleotides of an array. The identifier sequences comprise a plurality of nucleotide blocks. Also provided are arrays of polynucleotides having identifier sequences, microparticles comprising said arrays, a plurality of 5 said microparticles, surfaces comprising said arrays, kits and methods for generating libraries using the array, methods for determining the accuracy of sequencing or amplification an array, and methods of analysing said libraries.
    Type: Application
    Filed: December 2, 2021
    Publication date: March 28, 2024
    Inventors: Martin PHILPOTT, Adam CRIBBS, Udo OPPERMANN, Tom BROWN, Jr., Tom BROWN, Sr., Jonathan Francis WATSON
  • POLYNUCLEOTIDE ARRAYS
    Publication number: 20230183794
    Abstract: The invention relates to micro-particles in which polynucleotides are joined to a bead at the 3? end and include a linker that can be cleaved to separate the polynucleotides from the bead and provide free 3? hydroxyl groups. Also provided are arrays of polynucleotides, pluralities of micro-particles, fluidic compartments comprising micro-particles, methods of synthesising the arrays and methods of generating libraries using the array.
    Type: Application
    Filed: May 13, 2021
    Publication date: June 15, 2023
    Inventors: Adam CRIBBS, Martin PHILPOTT, Udo OPPERMANN, Tom BROWN, JR., Tom BROWN, Jonathan Francis WATSON
  • Cancer treatment by combination therapy
    Patent number: 7510830
    Abstract: Methods and compositions are provided for treating cancer, the methods including the step administering, either sequentially or simultaneously, (i) a compound of the xanthenone acetic acid group of compounds, and (ii) at least one compound selected from compounds which modulate TNF production and compounds which act on biochemical pathways leading to TNF synthesis. Compositions include a combination of (i) and (ii) above, together with acceptable pharmaceutical carriers and/or vehicles.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: March 31, 2009
    Assignee: Cancer Research Technology Limited
    Inventors: Bruce Charles Baguley, Lai-Ming Ching, Martin Philpott
  • Cancer treatment by combination therapy
    Publication number: 20040087611
    Abstract: Methods and composition are provided for treating cancer, the methods including the step a administering, either sequentially or simultaneously, (i) a compound of the xanthenone acetic acid group of compounds, and (ii) at least one compound selected from compounds which modulate TNF production and compounds which act on biochemical pathways leading to TNF synthesis. Compositions include a combination of (i) and (ii) above, together with acceptable pharmaceutical carriers and/or vehicles.
    Type: Application
    Filed: January 14, 2003
    Publication date: May 6, 2004
    Inventors: Bruce Charles Baguley, Lai-Ming Ching, Martin Philpott